Bone mineral density and bone turnover in asthmatics treated with long-term inhaled or oral glucocorticoids

被引:67
|
作者
Ebeling, PR [1 ]
Erbas, B
Hopper, JL
Wark, JD
Rubinfeld, AR
机构
[1] Royal Melbourne Hosp, Dept Endocrinol & Diabet, Bone & Mineral Serv, Melbourne, Vic 3050, Australia
[2] Univ Melbourne, Dept Med, Melbourne, Vic, Australia
[3] Univ Melbourne, Dept Publ Hlth & Community Med, Melbourne, Vic, Australia
[4] Royal Melbourne Hosp, Dept Thorac Med, Melbourne, Vic 3050, Australia
关键词
D O I
10.1359/jbmr.1998.13.8.1283
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Inhaled glucocorticoids are pivotal in maintenance therapy of chronic bronchial asthma; however, conflict exists over their effects on bone and mineral metabolism. We measured bone mineral density (BMD), bone turnover markers, and adrenal steroid hormones in 53 patients (34 female, 19 male) with chronic bronchial asthma who had taken either inhaled beclomethasone or budesonide in doses of greater than or equal to 1500 mu g/day for at least 12 months to determine pathogenetic mechanisms of bone loss. To account for the effect of prior oral glucocorticoid exposure we divided patients into two groups: one with (OG) and the other without (IG) a past history of maintenance (> 1 month) oral glucocorticoid therapy. Lumbar spine (LS) and proximal femur BMDs were similar to 1 SD lower in men and women taking OG or high-dose IG for chronic bronchial asthma, potentially equivalent to a doubling of the risk of fracture at these sites. Prior exposure to OG in women was also associated with lower LS and proximal femur BMDs, while men were more sensitive to the adverse effects of IG on LS and Ward's triangle BMDs, Bone formation markers were decreased; however, bone resorption marker concentrations were normal. All patients had evidence of suppression of both endogenous glucocorticoid and adrenal androgen production. Both total duration of OG and biochemical bone turnover marker concentrations were negatively related to proximal femur and rib BMDs and total body bone mineral content, but not to LS BMD, These were stronger for bone resorption markers. Uncoupling of ongoing normal bone resorption from suppressed bone formation may therefore contribute to glucocorticoid-associated bone loss in asthma, Adrenal androgen suppression may also increase the susceptibility of postmenopausal women in particular to bone loss with OG, Although the effects of high-dose IG on BMD are associated with lower LS BMD in men, this observation should now be investigated further in prospective studies.
引用
收藏
页码:1283 / 1289
页数:7
相关论文
共 50 条
  • [31] Raloxifene increased bone mineral density in the spine and hips of postmenopausal women using long-term glucocorticoids
    Robbins, John
    ANNALS OF INTERNAL MEDICINE, 2011, 155 (06)
  • [32] DECREASED BONE-MINERAL DENSITY IN PREMENOPAUSAL ASTHMA PATIENTS RECEIVING LONG-TERM INHALED STEROIDS
    IP, M
    LAM, K
    YAM, L
    KUNG, A
    NG, M
    CHEST, 1994, 105 (06) : 1722 - 1727
  • [33] Impact of long-term inhaled corticosteroid therapy on bone mineral density: results of a meta-analysis
    Halpern, MT
    Schmier, JK
    Van Kerkhove, MD
    Watkins, M
    Kalberg, CJ
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2004, 92 (02) : 201 - 207
  • [34] Long-term follow up of bone mineral density, bone turnover markers and 25-hydroxyvitamin D in bone marrow transplant survivors
    Buehring, B.
    Krueger, D.
    Longo, W.
    Flynn, B.
    Binkley, N.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2007, 22 : S357 - S357
  • [35] BONE AND MINERAL METABOLISM IN BB RATS WITH LONG-TERM DIABETES - DECREASED BONE TURNOVER AND OSTEOPOROSIS
    VERHAEGHE, J
    VANHERCK, E
    VISSER, WJ
    SUIKER, AMH
    THOMASSET, M
    EINHORN, TA
    FAIERMAN, E
    BOUILLON, R
    DIABETES, 1990, 39 (04) : 477 - 482
  • [36] Effects of an oral contraceptive containing drospirenone on bone turnover and bone mineral density
    Nappi, C
    Sardo, AD
    Greco, E
    Tommaselli, GA
    Giordano, E
    Guida, M
    OBSTETRICS AND GYNECOLOGY, 2005, 105 (01): : 53 - 60
  • [37] Bone mineral density and bone turnover in postmenopausal women treated for breast cancer
    Waltman, Nancy L.
    Ott, Carol D.
    Twiss, Janice J.
    Gross, Gloria J.
    Lindsey, Ada M.
    Moore, Timothy E.
    CANCER NURSING, 2008, 31 (03) : 182 - 190
  • [38] Effects of long-term, experimental, mild hyperthyroidism on calcium balance, bone mineral density and bone turnover, in healthy young men
    Smith, SR
    Lovejoy, JC
    Bray, GA
    JOURNAL OF INVESTIGATIVE MEDICINE, 1996, 44 (01) : A74 - A74
  • [39] Bone mineral density in long-term survivors of childhood cancer
    Hesseling, PB
    Hough, SF
    Nel, ED
    van Riet, FA
    Beneke, T
    Wessels, G
    INTERNATIONAL JOURNAL OF CANCER, 1998, 78 : 44 - 47
  • [40] Bone Mineral Density in Children with Long-Term Antiepileptic Therapy
    Dimic, Milena
    Dimic, Aleksandar
    Milosevic, Zoran
    Vojinovic, Jelena
    SRPSKI ARHIV ZA CELOKUPNO LEKARSTVO, 2013, 141 (5-6) : 329 - 332